 |
Article dans une revue
Enzyme replacement therapy for pancreatic insufficiency: present and future.
Abstract : Pancreatic enzyme replacement therapy is currently the mainstay of treatment for nutrient malabsorption secondary to pancreatic insufficiency. This treatment is safe and has few side effects. Data demonstrate efficacy in reducing steatorrhea and fat malabsorption. Effective therapy has been limited by the ability to replicate the physiologic process of enzyme delivery to the appropriate site, in general the duodenum, at the appropriate time. The challenges include enzyme destruction in the stomach, lack of adequate mixing with the chyme in the duodenum, and failing to deliver and activate at the appropriate time. Treatment is begun when clinically significant malabsorption occurs resulting in steatorrhea and weight loss. Treatment failure is addressed in a sequential fashion. Current research is aimed at studying new enzymes and delivery systems to improve the efficiency of action in the duodenum along with developing better means to monitor therapy.
Littérature citée [197 références]
https://www.hal.inserm.fr/inserm-00701598
Déposant : Martine Armand <>
Soumis le : vendredi 25 mai 2012 - 18:08:55
Dernière modification le : mardi 20 octobre 2020 - 10:51:56
Archivage à long terme le : : dimanche 26 août 2012 - 03:00:53
Déposant : Martine Armand <>
Soumis le : vendredi 25 mai 2012 - 18:08:55
Dernière modification le : mardi 20 octobre 2020 - 10:51:56
Archivage à long terme le : : dimanche 26 août 2012 - 03:00:53
Fichier
CEG-17634-enzyme-replacement-t...
Fichiers éditeurs autorisés sur une archive ouverte
Données personnelles 
Mentions légales 